Article
MTRR 66A>G polymorphism in relation to congenital heart defects.
Clinical chemistry and laboratory medicine - 1 Jan 2006
van Beynum Ingrid M, Kouwenberg Margreet, Kapusta Livia, den Heijer Martin, van der Linden Ivon J M, Daniels Otto, Blom Henk J
Abstract excerpt
BACKGROUND: Evidence is accumulating that periconceptional folic acid supplementation may prevent congenital heart defects (CHD). The methionine synthase reductase (MTRR) enzyme restores methionine synthase (MTR) enzyme activity and therefore plays an essential role in the folate- and vitamin B(12)-dependent remethylation of homocysteine to methionine. We studied the influence of the MTRR 66A>G polymorphism on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
